                         SEQUENCE LISTING

<110>  University of Connecticut
 
<120>  Nucleic Acid Nanocapsules for Drug Delivery and Targeted Gene 
       Knockdown

<130>  17-728-PCT

<150>  US 62/523,929
<151>  2017-06-23

<160>  12    

<170>  PatentIn version 3.5

<210>  1
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  AKH-anchor


<220>
<221>  misc_structure
<222>  (1)..(1)
<223>  SH

<400>  1
tttttttttt cacgtccagc ag                                                22


<210>  2
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GATA-3 DNAzyme


<220>
<221>  misc_structure
<222>  (1)..(1)
<223>  monophosphorylated site

<400>  2
gtggatggag gctagctaca acgagtcttg gag                                    33


<210>  3
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GATA-3 DNAzyme bridge

<400>  3
gcctccatcc acctgctgga cgtg                                              24


<210>  4
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Mutated DNAzyme


<220>
<221>  misc_structure
<222>  (1)..(1)
<223>  monophosphorylated site

<400>  4
gcggctggag gctagctaca acgagtctcg tag                                    33


<210>  5
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Mutated DNAzyme bridge

<400>  5
gcctccagcc gcctgctgga cgtg                                              24


<210>  6
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  GATA-3 mRNA truncate 1


<220>
<221>  misc_structure
<222>  (1)..(1)
<223>  Cy3

<400>  6
cuccaagacg uccauccac                                                    19


<210>  7
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  GATA-3 mRNA truncate 2


<220>
<221>  misc_structure
<222>  (1)..(1)
<223>  dye FAM

<220>
<221>  misc_structure
<222>  (19)..(19)
<223>  black hole quencher (BHQ)

<400>  7
cuccaagacg uccauccac                                                    19


<210>  8
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cathepsin B substrate

<400>  8

Cys Gly Phe Leu Gly Cys 
1               5       


<210>  9
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MMP9 substrate

<400>  9

Cys Gly Pro Leu Gly Leu Ala Gly Gly Glu Arg Asp Gly Cys 
1               5                   10                  


<210>  10
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide linker

<400>  10

Gly Pro Leu Gly Leu Ala Gly Gly Glu Arg Asp Gly 
1               5                   10          


<210>  11
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide linker

<400>  11

Gly Phe Leu Gly 
1               


<210>  12
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide linker

<400>  12

Gly Pro Met Gly Ile Ala Gly Gln 
1               5               


